Research programme: cancer therapeutics - Unibioscreen
Alternative Names: UNBS 3243Latest Information Update: 04 Nov 2017
At a glance
- Originator Unibioscreen
- Class Fluoroquinolones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Cancer in Belgium
- 26 Mar 2009 Preclinical development is ongoing in Belgium
- 18 Sep 2007 Early research in Cancer in Belgium (unspecified route)